Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec departure
confidence 85%
filed 2026-06-18
Item 5.02
J. Wesley Sutherland's departure as Chief Accounting Officer effective June 16, 2026, is the principal disclosed action. While the filing also mentions Walter J. Phifer assuming the interim Principal Accounting Officer role, the core event centers on Sutherland's departure and planned retirement on September 30, 2026. The Chief Accounting Officer is a named executive officer responsible for financial reporting integrity, making this departure material to investors.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Item 8.01
Enphase entered into a Tax Credit Transfer Agreement to sell up to $150 million in advanced manufacturing production tax credits (Section 45X) for up to $139.5 million in cash payments over 2026-2027. While this is a material transaction affecting liquidity and cash flow, it does not fit cleanly into the standard M&A, financing, or compensation categories—it is a specialized tax credit monetization arrangement. The materiality is evident from the substantial dollar amounts and the Company's explicit forward-looking statements about its ability to generate and receive payments for such credits.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 16, 2026. The filing reports voting outcomes for two proposals: (1) election of Class I directors Julie A. Cullivan and John C.M. Farquhar, and (2) ratification of PricewaterhouseCoopers LLP as independent auditor. Both proposals passed with substantial majorities. This is a material event as it reflects stockholder approval of board composition and auditor selection.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-06-18
Item 1.01
The filing discloses a material settlement agreement resolving antitrust class action litigation (In re: PVC Pipe Antitrust Litigation) for $30 million. Although Item 1.01 is cited, the substance is a material litigation settlement that materially affects the company's financial position and reduces significant legal exposure and uncertainty. The $30 million settlement payment and resolution of End-User class claims constitute a material event requiring disclosure under 8-K Item 8.01 (Other Events) or as a material settlement, which falls under material_litigation in this taxonomy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-18
Item 2.02
Accenture disclosed its third-quarter fiscal 2026 financial results on June 18, 2026, via a news release attached as Exhibit 99. The disclosure includes Q3 FY26 revenues of $18.7 billion (6% growth in U.S. dollars, 3% in local currency), diluted EPS of $3.80 (9% increase), operating margin expansion to 17.0%, and free cash flow of $3.6 billion, along with updated full-year fiscal 2026 guidance. This is a standard quarterly earnings release material to investors.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-06-18
Item 8.01
Regenerex Pharma commenced litigation against Optimize Health Partners, LLC (owned by the Company's former CFO Kenneth W. Perry) seeking recovery of approximately $37,285 in overbilled amounts plus additional damages, restitution, and injunctive relief. The complaint alleges material breaches of a software license agreement including improper invoice inflation, unauthorized markups, failure to deposit escrow materials, and failure to maintain required insurance—all involving mission-critical healthcare software infrastructure. This is a material litigation disclosure under Item 8.01 that would affect a reasonable investor's assessment of the registrant's financial exposure and operational risks.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-18
Item 3.02
The Company issued 545,591 shares of common stock to Lind Global Asset Management in satisfaction of payment obligations under a $7.5 million senior secured convertible promissory note. The issuances occurred on June 17, 2026 and May 19, 2026, relying on Section 3(a)(9), Section 4(a)(2), and/or Regulation D exemptions. This is a dilutive equity issuance to an existing securityholder in connection with debt repayment obligations, which materially affects share count and ownership structure.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-18
EX-99.1
This press release announces the completion of equipment procurement agreements totaling $242.3 million USD across 23 distributed solar and energy storage projects, securing safe harbor status under U.S. federal Investment Tax Credit rules. The disclosure is primarily operational and strategic—describing project development milestones, tax credit eligibility ($94.7 million estimated value), and capacity metrics (97 MW DC solar, 42 MWh storage)—rather than fitting a specific financial or governance category. While the projects represent significant capital deployment and tax benefits, the core announcement is the operational achievement of procurement completion and regulatory compliance positioning, making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
Dragonfly Energy announced receipt of a patent allowance from the USPTO for "Powderized Solid-State Electrolyte and Electroactive Materials," directed at manufacturing processes supporting the company's solid-state battery development. While this is a positive intellectual property development, it does not fit neatly into the standard 8-K event taxonomy (not earnings, M&A, executive changes, impairments, etc.). Patent allowances can be material to technology companies' competitive positioning and future revenue potential, particularly in battery development where IP is strategically important.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
The filing discloses an extension of the maturity date of a $3,000,000 unsecured revolving note from July 5, 2026 to July 7, 2027. While this is a material financing arrangement with a related party (ProdActive II, LLC, linked to the Founder/CEO), it does not fit cleanly into the standard taxonomy: it is neither a new debt covenant breach, a dilutive issuance, nor a traditional M&A event. The extension preserves access to low-interest financing and is material to investor assessment of the company's liquidity and capital structure, but the specific event—a maturity extension rather than a new borrowing or default—is best classified as other_material.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-18
The 6-K discloses a private placement of 862,069 ordinary shares at $0.58 per share for $500,000 aggregate proceeds, executed pursuant to Regulation S. The Securities Purchase Agreement includes a 24-month lock-up on further issuances and registration statements, which is characteristic of dilutive equity financing. This unregistered sale of equity securities is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-06-18
The 8-K discloses Earth Science Tech's fiscal year-end financial results for March 31, 2026, via a press release attached as Exhibit 99.1. Item 2.02 explicitly states "On June 18, 2026, the Company issued a press release (the 'Release') reporting its fiscal year-end financial results for March 31, 2026." The filing includes consolidated balance sheets and statements of operations showing revenue of $35.7 million (up 8%), net income of $3.6 million (up 11%), and total assets of $9.0 million (up 27%), along with management commentary on operational performance and capital allocation.
View raw filing on EDGAR →
6-K
Governance Other
confidence 92%
filed 2026-06-18
The 6-K discloses a 1-for-6 reverse stock split approved by shareholders at an Extraordinary General Meeting on June 8, 2026, and implemented via Memorandum Amendment filed June 10, 2026, effective June 29, 2026. This is a governance and capital structure event affecting all shareholders' holdings and trading mechanics. While not fitting a specific named governance category (exec appointment, departure, compensation, or shareholder vote results), it is clearly a material governance action that would affect a reasonable investor's assessment of share ownership and market trading.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-18
The 6-K discloses the appointment of Ms. Mei Wang as Chief Financial Officer effective June 17, 2026, following the resignation of the prior CFO. While both a departure and appointment occurred, the principal disclosed action is the appointment of a named executive to a C-suite role. The disclosure includes detailed biographical information, qualifications, and Board rationale, consistent with material executive appointment disclosures under Item 5.02.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-06-18
EX-99.1
Peter H. Puccetti, who has been serving as Interim CEO since November, has been appointed as the Company's permanent full-time President and CEO effective immediately.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-06-18
EX-99.2
The Company's annual general and special meeting of shareholders held on June 17, 2026 approved three material matters: election of six directors, appointment of Deloitte LLP as auditors, and approval of a special resolution to consolidate and subsequently split the Company's common shares.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
The filing discloses a comprehensive update on Eightco's treasury composition and strategic holdings as of June 18, 2026, totaling approximately $472 million. The press release highlights material positions in OpenAI ($90M), Beast Industries ($18M), 283+ million WLD tokens, and 16,278 ETH, along with significant cash holdings. While this is disclosed under Item 7.01 (Regulation FD Disclosure) rather than a traditional earnings release, the detailed quantification of material assets and strategic investments would affect a reasonable investor's assessment of the company's financial position and asset base. The disclosure does not fit neatly into earnings_release (no financial results), ma_activity (no transaction), or other specific categories, making other_material the most appropriate classification.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-06-18
Dyadic received a notification from Nasdaq on June 18, 2026 initiating delisting proceedings due to failure to maintain the minimum $1.00 bid price (Nasdaq Listing Rule 5450(a)(1)) and failure to meet continued listing standards under Rule 5550(b). The company has neither regained compliance nor met conditions for extension as of the filing date, and faces potential delisting despite plans to request a hearing before a Nasdaq panel.
View raw filing on EDGAR →
6-K
M&A activity
confidence 98%
filed 2026-06-18
EX-99.1
The exhibit is a Form 51-102F3 Material Change Report disclosing the closing of Draganfly's acquisition of Skip Dynamix Corporation (now Pwise, Inc.) on June 11, 2026, for an aggregate purchase price of up to US$7,525,000 in cash, equity, and earn-out consideration. This is a completed material acquisition meeting the definition of ma_activity.
View raw filing on EDGAR →
8-K
Bankruptcy Filing
confidence 95%
filed 2026-06-18
The filing discloses that Fat Brands Inc. and its subsidiaries, including Twin Hospitality Group Inc., commenced voluntary Chapter 11 bankruptcy cases on January 26, 2026, in the U.S. Bankruptcy Court for the Southern District of Texas. The 8-K documents the bankruptcy proceedings, asset sales conducted pursuant to bankruptcy court orders, and the completion of multiple asset dispositions. While the filing also contains M&A activity (asset sales), the foundational event is the Chapter 11 filing itself, which is the terminal signal requiring disclosure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-06-18
The filing discloses multiple material events, but the dominant theme is substantial dilutive equity issuances. Item 3.02 reports unregistered sales of common stock totaling approximately 3.8 million shares issued to lenders and preferred stockholders (Streeterville and 1800 Diagonal) in conversion transactions and exchanges occurring June 15-17, 2026. Item 1.01 describes entry into three debt instruments (Quick Capital Note, 1800 Diagonal Note, and Streeterville exchanges) with conversion rights that trigger further dilution. While the filing also involves debt covenant obligations (Item 2.03), the primary disclosed activity centers on the issuance of unregistered equity securities as consideration for debt restructuring and preferred stock conversions, which is characteristic of dilutive_issuance events at small-cap issuers under financial stress.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
The filing discloses completion of a material acquisition whereby SRx Health Solutions acquired 100% of EMJ Crypto Technologies Inc. and CCC Crypto Corp., issuing 268.3 million shares of common stock, 117.3 million exchangeable shares, and 44.4 million pre-funded warrants. The transaction fundamentally transforms the company's business strategy and results in a name change to SRX Global Inc., clearly constituting a material change of control and M&A activity under Item 1.01/2.01.
View raw filing on EDGAR →
8-K
Other material
confidence 72%
filed 2026-06-18
The filing discloses termination of a technology license agreement and services agreement with Lightning Silicon Technology, Inc., coupled with a complete exit from equity holdings in both LST and LS Assets through share repurchases for nominal consideration ($1.00 each for 18 million shares). While the company states it does not expect material financial effects, the termination of a technology license and complete divestiture of equity stakes in what appears to be a significant business relationship represents a material strategic event affecting the registrant's business operations and future revenue streams (including the royalty arrangement through October 2026).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-18
The filing discloses a Stock Purchase Agreement (Item 1.01) under which NextNRG issued 260,000 shares of common stock to CEO Michael D. Farkas at $0.386 per share in exchange for debt forgiveness of $100,360. This is a dilutive equity issuance to an insider (the CEO and significant stockholder) in lieu of cash payment, which is a material capital structure event. The concurrent termination of the underlying promissory note (Item 1.02) confirms the debt-for-equity nature of the transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
The filing discloses LIXTE's entry into a material definitive merger agreement with NOMAD Transportable Power Systems, Inc., dated June 11, 2026, whereby NOMAD will merge into a subsidiary with NOMAD surviving as a wholly-owned subsidiary of LIXTE. Additionally, on June 17, 2026, LIXTE issued a $6.5 million Secured Promissory Note to NOMAD to fund working capital and repay NOMAD's existing debt obligations in connection with the merger. The press release confirms the transaction is expected to close on or about July 1, 2026, and the combined company will be renamed NOMAD Power Solutions, Inc. This constitutes a material acquisition and change of control transaction under Item 1.01.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-18
EX-99.1
This press release announces successful completion of rig mobilization, safety checks, and setup at the Kruh Block, with confirmation that drilling of the first planned well (K-29) remains on schedule for late June 2026. The disclosure details a material operational milestone in IEC's core exploration and production strategy, including specific timelines for rig-up, function testing, government inspection, and spud date. While not fitting a named operational category, this represents a significant operational development affecting the company's ability to execute its 2026 drilling program and generate future production.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-06-18
The filing discloses completion of a share exchange transaction on June 15, 2026, whereby Addentax Group Corp.'s subsidiary Yingxi acquired 41.67% equity interests in Riches Family Office Limited in exchange for issuance of 33,500 common shares to Mr. Wu Rui (the Company's COO). This constitutes a material acquisition of assets under Item 2.01, coupled with an unregistered equity issuance under Item 3.02 (Regulation S offshore transaction). The transaction involves a change in ownership structure and equity dilution material to investors.
View raw filing on EDGAR →
8-K
Covenant Breach
confidence 72%
filed 2026-06-18
The filing discloses an amendment to a revolving credit agreement with Citibank that modifies an affirmative covenant relating to the Fixed Charge Coverage Ratio by adding cash interest expenses to the denominator. This modification, combined with a one-year extension of the promissory note maturity (from February 2027 to February 2028), suggests the Company sought relief from a tightening financial covenant—a classic indicator of covenant stress or imminent breach. While not explicitly stated as a breach, the amendment's timing and nature signal financial pressure that would be material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
The filing discloses results of Verano Holdings Corp.'s 2026 Annual Meeting of Stockholders held on June 18, 2026, under Item 5.07. Four proposals were submitted to stockholder vote: election of five directors, advisory approval of named executive officer compensation (Say-on-Pay), ratification of independent auditor Macias Gini & O'Connell LLP, and reapproval of the Stock and Incentive Plan. All proposals passed with substantial majorities, making this a routine but material shareholder vote disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The filing discloses results of the 2026 Annual Meeting of stockholders held on June 18, 2026, including election of six directors, ratification of Grant Thornton LLP as independent auditor, and approval of the Amended and Restated Incentive Award Plan with voting tallies for each proposal. This is a classic Item 5.07 shareholder vote results disclosure, material to investors as it confirms board composition and equity plan expansion (3,000,000 additional shares authorized).
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
PHP Ventures Acquisition Corp. disclosed under Item 8.01 that it deposited $957.30 into its trust account to extend the deadline for completing an initial business combination by one month (from June 16 to July 16, 2026). This is a material event for a SPAC facing a deadline extension, though it does not fit neatly into the standard taxonomy categories. The company was already suspended from Nasdaq trading as of April 2024, making the extension effort material to investors assessing the registrant's viability.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-06-18
The filing discloses a Nasdaq notification letter (Item 3.01) stating that Algorhythm Holdings' common stock has failed to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The company has been granted a 180-calendar-day compliance period (until December 14, 2026) to regain compliance, with potential delisting if it fails to do so. This is a clear delisting risk disclosure that would materially affect investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-18
The filing discloses the appointment of Peter Hansen-Chambers as Chief Financial Officer effective July 1, 2026, along with a concurrent transition of Stanley Beckley from CFO to Chief Accounting and Compliance Officer. While both an appointment and a departure occur, the principal disclosed action centers on the appointment of Hansen-Chambers to the CFO role, supported by detailed biographical information, employment agreement terms, and a press release announcing the leadership evolution. The filing emphasizes Hansen-Chambers' 20 years of gaming industry experience and his track record scaling businesses, indicating this is a material executive appointment to a key financial leadership position.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
The filing discloses Item 5.07 results from Manhattan Bridge Capital's 2026 Annual Meeting of Shareholders held on June 18, 2026, including voting results for the election of six directors (Assaf Ran, Lyron Bentovim, Eran Goldshmit, Michael Jackson, Vanessa Kao, and Phillip Michals) and advisory approval of Hoberman & Lesser, LLP as independent auditors. This is a standard shareholder vote results disclosure that is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-06-18
The 6-K discloses that ZOOZ Strategy Ltd. received a Nasdaq notice on December 16, 2025, for non-compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) due to closing bid prices below $1.00 for 30 consecutive business days. The company was given 180 days to regain compliance by June 15, 2026. The filing now reports that the company has regained compliance as of June 12, 2026, and Nasdaq has formally closed the deficiency matter. This is a material delisting-risk disclosure because it directly addresses a continued listing rule violation and the company's status in regaining compliance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-06-18
Item 1.01
Item 1.01 discloses a private placement of shares ("Shares") offered and issued under Section 4(a)(2) and Regulation D exemptions, with an Amendment No. 1 to Registration Rights Agreement dated June 18, 2026. The filing explicitly states the Shares were unregistered and issued without general solicitation, which is characteristic of a dilutive equity issuance. The forward-looking statements reference risks related to executing growth strategy and maintaining listing compliance, consistent with a capital raise by a smaller-cap company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The filing discloses results from Calidi Biotherapeutics' 2026 Annual Meeting of Stockholders held on June 12, 2026, under Item 5.07. Four proposals were voted on and approved: election of Scott Leftwich as Class III Director, ratification of CBIZ CPAs P.C. as auditor, approval of a reverse stock split (1-for-2 to 1-for-16 ratio at board discretion), and amendment to the 2023 Equity Incentive Plan to increase authorized shares from 282,815 to 1,950,000. The reverse stock split and equity plan amendment are material corporate actions affecting share structure and equity compensation capacity.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-06-18
The filing discloses a $50,000 extension payment deposited into the trust account to extend the business combination deadline by one month (from June 19 to July 19, 2026), reported under Item 2.03 (Creation of a Direct Financial Obligation). While this creates a direct financial obligation, it does not fit neatly into the standard taxonomy categories—it is neither a covenant breach (no violation), nor a dilutive issuance, nor M&A activity per se, but rather a procedural extension mechanism for a SPAC. The materiality is moderate: it signals the company has not yet completed its business combination and is incurring costs to extend the deadline, which is relevant to investors assessing the SPAC's progress and timeline.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-18
The filing discloses a completed public offering of 1,040,000 shares of common stock and 2,960,000 pre-funded warrants (exercisable for common stock) for aggregate gross proceeds of $3.2 million, consummated on June 16, 2026 under Item 1.01. The pre-funded warrants are immediately exercisable at $0.007 per share and represent substantial dilution to existing shareholders. This is a material equity issuance that would affect investor assessment of ownership and capital structure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-06-18
The filing discloses entry into non-redemption agreements (Non-Redemption Agreements) with third-party shareholders in connection with a previously announced business combination between Digital Asset Acquisition Corp. and Old Glory Holding Company. The agreements commit shareholders to not redeem their shares in exchange for warrant consideration, which is a material definitive agreement directly supporting the business combination transaction. Item 1.01 explicitly states "Entry into a Material Definitive Agreement," and the substance involves material consideration (3.25 warrants per share) tied to a change-of-control transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The 8-K discloses results of the June 15, 2026 Annual Meeting of Stockholders under Item 5.07, reporting voting outcomes for three matters: election of five directors (with vote tallies for each nominee), advisory approval of named executive officer compensation, and ratification of Grassi & Co., CPAs as independent auditor. These are standard shareholder vote results that materially inform investors about governance and board composition.
View raw filing on EDGAR →
6-K
Going Concern
confidence 75%
filed 2026-06-18
EX-99.1
Robot Consulting Co., Ltd. disclosed substantial doubt about its ability to continue as a going concern in its 6th Annual General Meeting notice and accompanying financial statements. The company reported a net loss of ¥1.49 billion for fiscal year ended March 31, 2026, accumulated deficit of ¥3.72 billion, and negative net assets of ¥602 million, with explicit going-concern language in the Notes to Financial Statements.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-06-18
The filing discloses Item 5.07 results from NetSol Technologies' annual shareholder meeting held June 18, 2026, including voting outcomes for three proposals: election of seven directors (with detailed vote tallies for each), advisory approval of named executive officer compensation (77.51% in favor), and ratification of Fortune CPA, Inc. as auditors (98.64% in favor). This is a standard shareholder vote results disclosure material to investors assessing governance and board composition.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-06-18
Item 3.02
Bandwidth Inc. issued $316.25 million aggregate principal amount of 0% convertible senior notes due 2032 in a private placement under Rule 144A and Section 4(a)(2), with conversion into up to 5,986,169 shares of Class A common stock at an initial conversion price of approximately $72.64 per share, creating substantial dilution potential for existing shareholders.
View raw filing on EDGAR →
8-K
Other material
confidence 80%
filed 2026-06-18
Item 8.01
Bandwidth Inc. repurchased approximately $122.5 million in aggregate principal amount of its 2028 notes for $116.5 million in cash, reducing outstanding debt by over 80% and materially altering the company's financial structure and leverage profile.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-18
Item 5.02
The filing discloses the appointment of Peter Owino as Interim Chief Accounting Officer effective June 12, 2026, and the designation of Bob Rasmus as principal financial officer. While the section also includes compensatory terms (hourly fee of $350 capped at $63,000 monthly), the principal disclosed action is the appointment of individuals to key accounting and financial officer roles. The appointment of an interim CAO to fill a principal accounting officer position is material to investors assessing the company's financial reporting infrastructure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-18
Item 5.07
This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Stockholders held on June 17, 2026, filed under Item 5.07. The filing reports voting outcomes on four proposals: election of eight directors, ratification of BDO USA as independent auditor, Say-on-Pay advisory vote approval, and Say-on-Frequency advisory vote (annual frequency approved). The detailed vote tallies for each proposal and nominee are provided, making this a textbook shareholder_vote_results event that is material to investors assessing board composition and governance.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-18
The Board of Directors approved a share buyback program authorizing the repurchase of up to 18 million common shares (1.61% of capital stock) through June 17, 2027, for use in stock-based incentive plans, treasury maintenance, or subsequent sale/cancellation. While technically a capital allocation decision, share repurchases are classified as dividend_distribution under the taxonomy as they represent a return of capital to shareholders. The program is material as it involves significant authorized spending (up to R$7.66 billion in available reserves) and affects shareholder value and capital structure.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 75%
filed 2026-06-18
Ultrapar's Board of Directors approved a share buyback program on June 17, 2026, authorizing repurchase of up to 18 million common shares (1.61% of share capital) over 12 months. While share repurchases are capital-allocation events distinct from dividends, they function as a return of capital to shareholders and are classified under the dividend_distribution category as a form of shareholder distribution. The program is material as it represents a significant capital deployment decision affecting shareholder value and the company's financial position.
View raw filing on EDGAR →
6-K
Earnings release
confidence 92%
filed 2026-06-18
EX-99.1
This exhibit is a press release announcing Q1 2026 financial results for Trinity Biotech, including revenue of $10.8m (43% increase YoY), gross margin improvement from 25.2% to 35.4%, and net loss reduction from $8.8m to $4.4m. The disclosure also announces significant product orders (2+ million TrinScreen HIV tests) expected to contribute to 2026 revenue and profitability targets. This is a material earnings release with forward-looking guidance affecting investor assessment of financial performance and outlook.
View raw filing on EDGAR →